Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole plus Misoprostol vs Misoprostol Alone for Early Pregnancy Loss
NCT05940233Completed
- Sponsor
- Queen Savang Vadhana Memorial Hospital
- Start
- Jun 2023
- Primary completion
- May 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of letrozole in early pregnancy loss (EPL) (2 arms), sponsored by Queen Savang Vadhana Memorial Hospital. Primary endpoint: Rate of complete abortion at 7 days. Started Jun 2023; status: completed.
02
Drugs
letrozole
03
Conditions
early pregnancy loss (EPL)
Beyond the preview
Go deeper on NCT05940233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05940233.